Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

Valerio Giannelli, Michela Giusto, Alessio Farcomeni, Francesca R. Ponziani, Maurizio Pompili, Raffaella Viganò, Rosa Maria Iemmolo, Maria F. Donato, Maria Rendina, Pierluigi Toniutto, Luisa Pasulo, Maria Cristina Morelli, Eleonora De Martin, Lucia Miglioresi, Daniele Di Paolo, Stefano Fagiuoli, Manuela Merli

Research output: Contribution to journalArticle

Abstract

It has been recently suggested that the risk of graft loss after liver transplantation (LT) may increase in female HCV patients. The aim of the study was to examine gender differences in HCV therapy tolerance and outcome in LT patients treated for HCV recurrence. A retrospective study was conducted on liver recipients with HCV recurrence, who were given antiviral therapy from 2001 to 2009 in 12 transplant centers in Italy. Sustained virological response (SVR), adherence-to-therapy, and side effects were evaluated. A multivariate logistic regression model was used after adjusting for possible confounders. The data regarding 342 treated patients were analyzed. SVR was reported in 38.8% of patients. At baseline, male and female did not differ in HCV viral load, histology, or rate of diabetes. SVR was lower in females than in males (29.5% vs. 42.1%; P = 0.03). Adherence-to-therapy was also lower in females than in males 43.4% vs. 23.8%; P = 0.001); anemia was the main reason for lower adherence. In a multivariate analysis in patients Genotype 1, female gender (P <0.04), early virological response (P <0.0001), and adherence to therapy (P <0.0001) were independent predictors for SVR. In conclusion, female gender represents an independent negative prognostic factor for the outcome of HCV antiviral therapy after LT.

Original languageEnglish
Pages (from-to)448-454
Number of pages7
JournalTransplant International
Volume25
Issue number4
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Hepatitis C
Recurrence
Liver
Liver Transplantation
Antiviral Agents
Therapeutics
Logistic Models
Transplants
Viral Load
Italy
Transplant Recipients
Anemia
Histology
Multivariate Analysis
Retrospective Studies
Genotype

Keywords

  • adherence
  • antiviral treatment
  • gender
  • HCV
  • liver transplant

ASJC Scopus subject areas

  • Transplantation

Cite this

Giannelli, V., Giusto, M., Farcomeni, A., Ponziani, F. R., Pompili, M., Viganò, R., ... Merli, M. (2012). Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. Transplant International, 25(4), 448-454. https://doi.org/10.1111/j.1432-2277.2012.01440.x

Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. / Giannelli, Valerio; Giusto, Michela; Farcomeni, Alessio; Ponziani, Francesca R.; Pompili, Maurizio; Viganò, Raffaella; Iemmolo, Rosa Maria; Donato, Maria F.; Rendina, Maria; Toniutto, Pierluigi; Pasulo, Luisa; Morelli, Maria Cristina; De Martin, Eleonora; Miglioresi, Lucia; Di Paolo, Daniele; Fagiuoli, Stefano; Merli, Manuela.

In: Transplant International, Vol. 25, No. 4, 04.2012, p. 448-454.

Research output: Contribution to journalArticle

Giannelli, V, Giusto, M, Farcomeni, A, Ponziani, FR, Pompili, M, Viganò, R, Iemmolo, RM, Donato, MF, Rendina, M, Toniutto, P, Pasulo, L, Morelli, MC, De Martin, E, Miglioresi, L, Di Paolo, D, Fagiuoli, S & Merli, M 2012, 'Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients', Transplant International, vol. 25, no. 4, pp. 448-454. https://doi.org/10.1111/j.1432-2277.2012.01440.x
Giannelli, Valerio ; Giusto, Michela ; Farcomeni, Alessio ; Ponziani, Francesca R. ; Pompili, Maurizio ; Viganò, Raffaella ; Iemmolo, Rosa Maria ; Donato, Maria F. ; Rendina, Maria ; Toniutto, Pierluigi ; Pasulo, Luisa ; Morelli, Maria Cristina ; De Martin, Eleonora ; Miglioresi, Lucia ; Di Paolo, Daniele ; Fagiuoli, Stefano ; Merli, Manuela. / Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. In: Transplant International. 2012 ; Vol. 25, No. 4. pp. 448-454.
@article{7dbf77f4064c448483659efc404d3efb,
title = "Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients",
abstract = "It has been recently suggested that the risk of graft loss after liver transplantation (LT) may increase in female HCV patients. The aim of the study was to examine gender differences in HCV therapy tolerance and outcome in LT patients treated for HCV recurrence. A retrospective study was conducted on liver recipients with HCV recurrence, who were given antiviral therapy from 2001 to 2009 in 12 transplant centers in Italy. Sustained virological response (SVR), adherence-to-therapy, and side effects were evaluated. A multivariate logistic regression model was used after adjusting for possible confounders. The data regarding 342 treated patients were analyzed. SVR was reported in 38.8{\%} of patients. At baseline, male and female did not differ in HCV viral load, histology, or rate of diabetes. SVR was lower in females than in males (29.5{\%} vs. 42.1{\%}; P = 0.03). Adherence-to-therapy was also lower in females than in males 43.4{\%} vs. 23.8{\%}; P = 0.001); anemia was the main reason for lower adherence. In a multivariate analysis in patients Genotype 1, female gender (P <0.04), early virological response (P <0.0001), and adherence to therapy (P <0.0001) were independent predictors for SVR. In conclusion, female gender represents an independent negative prognostic factor for the outcome of HCV antiviral therapy after LT.",
keywords = "adherence, antiviral treatment, gender, HCV, liver transplant",
author = "Valerio Giannelli and Michela Giusto and Alessio Farcomeni and Ponziani, {Francesca R.} and Maurizio Pompili and Raffaella Vigan{\`o} and Iemmolo, {Rosa Maria} and Donato, {Maria F.} and Maria Rendina and Pierluigi Toniutto and Luisa Pasulo and Morelli, {Maria Cristina} and {De Martin}, Eleonora and Lucia Miglioresi and {Di Paolo}, Daniele and Stefano Fagiuoli and Manuela Merli",
year = "2012",
month = "4",
doi = "10.1111/j.1432-2277.2012.01440.x",
language = "English",
volume = "25",
pages = "448--454",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

AU - Giannelli, Valerio

AU - Giusto, Michela

AU - Farcomeni, Alessio

AU - Ponziani, Francesca R.

AU - Pompili, Maurizio

AU - Viganò, Raffaella

AU - Iemmolo, Rosa Maria

AU - Donato, Maria F.

AU - Rendina, Maria

AU - Toniutto, Pierluigi

AU - Pasulo, Luisa

AU - Morelli, Maria Cristina

AU - De Martin, Eleonora

AU - Miglioresi, Lucia

AU - Di Paolo, Daniele

AU - Fagiuoli, Stefano

AU - Merli, Manuela

PY - 2012/4

Y1 - 2012/4

N2 - It has been recently suggested that the risk of graft loss after liver transplantation (LT) may increase in female HCV patients. The aim of the study was to examine gender differences in HCV therapy tolerance and outcome in LT patients treated for HCV recurrence. A retrospective study was conducted on liver recipients with HCV recurrence, who were given antiviral therapy from 2001 to 2009 in 12 transplant centers in Italy. Sustained virological response (SVR), adherence-to-therapy, and side effects were evaluated. A multivariate logistic regression model was used after adjusting for possible confounders. The data regarding 342 treated patients were analyzed. SVR was reported in 38.8% of patients. At baseline, male and female did not differ in HCV viral load, histology, or rate of diabetes. SVR was lower in females than in males (29.5% vs. 42.1%; P = 0.03). Adherence-to-therapy was also lower in females than in males 43.4% vs. 23.8%; P = 0.001); anemia was the main reason for lower adherence. In a multivariate analysis in patients Genotype 1, female gender (P <0.04), early virological response (P <0.0001), and adherence to therapy (P <0.0001) were independent predictors for SVR. In conclusion, female gender represents an independent negative prognostic factor for the outcome of HCV antiviral therapy after LT.

AB - It has been recently suggested that the risk of graft loss after liver transplantation (LT) may increase in female HCV patients. The aim of the study was to examine gender differences in HCV therapy tolerance and outcome in LT patients treated for HCV recurrence. A retrospective study was conducted on liver recipients with HCV recurrence, who were given antiviral therapy from 2001 to 2009 in 12 transplant centers in Italy. Sustained virological response (SVR), adherence-to-therapy, and side effects were evaluated. A multivariate logistic regression model was used after adjusting for possible confounders. The data regarding 342 treated patients were analyzed. SVR was reported in 38.8% of patients. At baseline, male and female did not differ in HCV viral load, histology, or rate of diabetes. SVR was lower in females than in males (29.5% vs. 42.1%; P = 0.03). Adherence-to-therapy was also lower in females than in males 43.4% vs. 23.8%; P = 0.001); anemia was the main reason for lower adherence. In a multivariate analysis in patients Genotype 1, female gender (P <0.04), early virological response (P <0.0001), and adherence to therapy (P <0.0001) were independent predictors for SVR. In conclusion, female gender represents an independent negative prognostic factor for the outcome of HCV antiviral therapy after LT.

KW - adherence

KW - antiviral treatment

KW - gender

KW - HCV

KW - liver transplant

UR - http://www.scopus.com/inward/record.url?scp=84858443752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858443752&partnerID=8YFLogxK

U2 - 10.1111/j.1432-2277.2012.01440.x

DO - 10.1111/j.1432-2277.2012.01440.x

M3 - Article

C2 - 22353419

AN - SCOPUS:84858443752

VL - 25

SP - 448

EP - 454

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 4

ER -